18May 2024
Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime

Mortality of Patients With Sepsis Administered Piperacillin-Tazobactam vs Cefepime

A recent study compared the effectiveness of piperacillin-tazobactam and cefepime in treating bacterial sepsis. While previous research hinted at adverse outcomes with piperacillin-tazobactam, this study found no significant difference in short-term outcomes at 14 days. However, analyzing a 15-month shortage of piperacillin-tazobactam revealed concerning results: piperacillin-tazobactam was associated with a 5.0% increase in 90-day mortality compared to cefepime, along with longer durations of organ dysfunction. This suggests that using piperacillin-tazobactam empirically in sepsis might be harmful.

  • #general medicine

Like

Save

Share